Speakers

Sarah Snykers

Head of Site Strategy & Excellence

Legend Biotech

Christine Le Bec

Deputy CTO, Head of Analytical Development & QC

Sensorion

Ketki Flannery

Associate Director MSAT and CMC

Autolous Therapeutics

Parag Kumthekar

Lead Gene Therapy Downstream Process Development

UCB

Rutger Douma

MSAT Advanced Therapies Director

Johnson & Johnson Innovative Medicine

Simone Zanetti

Global Head of QC Analytical Technologies, Gene Therapy

CSL Behring

Lia Ferreras

Senior Scientist – Analytical Development Group

Orchard Therapeutics

Nicole Lund

Senior Director of Analytical & Quality Control

BlueRock Therapeutics

Rolando Matos

Senior Scientist

Cell and Gene Therapy Catapult

A Representative

from

Pantherna Therapeutics

A Representative from Exogenus Therapeutics

-

Exogenus Therapeutics

Aadarash Zia

Senior Scientist - Drug Delivery

Medicines Discovery Catapult

Alberto Sada Japp

Senior Director - R&D

Captain T Cell

Aleck Jones

CEO

Kindling Bio

Andy Osborne

Vice President of Pre-Clinical Research

Ikarovec

Anette Brass

Head of Process Development

Anocca AB

Artemy Shumskiy

Principal

LongeVC

Dr. Bernd Giebel

Founder & CTO

Exosla Therapeutics

Bo Wiinberg

Chief Business Development Officer

Novo Nordisk Foundation Cellerator

Carolina Pola

Chief Executive Officer

STAb Therapeutics

Christian Kannemeier

Senior Investment Manager

High-Tech Gründerfonds Management GmbH

Christopher Locher

CEO & Co-Founder

Versatope, USA

Clotilde Ciesla

Upstream Development Engineer

Genethon

Clément Bonamy

Head of R&D Platform

Everzom

Céline Jaudouin

Senior Formulation Scientist

Alaya.bio

Gadareth Higgs

Head Healthcare & Life Sciences Partner

Advantary Capital Partners

Gonzalo Fernández-Miranda

CEO and Co-Founder

CureAge Therapeutics

Gray Kueberuwa

Chief Executive Officer

ImmunoKey Ltd

Gunther Busam

Vice President, Global Manufacturing Technology and Supply

Orchard Therapeutics

Heinrich Haas

Chief Technology Officer

NeoVac

Jan Schrooten

CEO

Antleron

Jenny van Asbeck-van der Wijst

CEO

Mercuna BV

Jordan Turnbull

Co-Founder, Co-CEO, CSO

Fuse Vectors

Ka-Wai Wan

Expert Pharmaceutical / Quality Assessor

MHRA

Katia Lemdani

Director Research and Development

Neovacs

Kuldeep Neote

CEO

Diadem Biotherapeutics

Lior Shaltiel

CEO

NurExone Biologic

Lorenz Knackstedt

Chief Technology Officer

NeutroGen Therapeutics

Lorenz Mayr

Managing Director

BioMedTech Consulting GmbH

Madhusudhan Reddy Bobbili

Universitätsassistent (Assistant Professor)

BOKU University

Manuel Vega

CEO

AGS Therapeutics

Matthias Bozza

Director, Head of Strategy and R&D

CPTx

Nic Preyat

Associate Director, Process Sciences, CMC Development - Gene Therapy

UCB

Ole Henrik Bang-Andreasen

Principal

Avant Bio

Paolo Morgese

VP Public Affairs EMEA

Alliance for Regenerative Medicine

Pranav Puri

Head BioProcess Development

VectorY

Rajeev Tawar

Associate Director, Vector and Analytical Development

Evox Therapeutics

Ramiz Saramati

QA Operations Expert

Novartis

Rammohan Devulapally

Sr. Director, Head of Nonviral Delivery

Granza Bio

Regine Heilbronn

Co-Founder and CEO

EpiBlok Therapeutics

Robert Mamoun

CEO

Ciloa

Shiran Shapira

CTO/CSO

Nano24

Steffen Goletz, PhD

Full Professor, Head of Biotherapeutic Glycoengineering and Immunology - Institute for Biotechnology & Biomedicine

Danish Technical University

Stephanie Sontag

Senior Research Scientist

Evotec International GmbH

Suzanne Saffie-Siebert

CEO

SiSaf Ltd

Sébastien Wang

Responsable R&D

Silon Therapeutics

Søren Sheikh

CEO

Blue Cell Therapeutics ApS

Thomas Chattaway

Senior Life Science Consultant

Independent

Ulf Grawunder

Co-founder & CEO

T-CURX

Volker Huppert

Chief Development Officer

Glycostem Therapeutics